Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice. Research peptides discussed are not FDA-approved for human use. Always consult a licensed healthcare professional. See our full disclaimer.
Quick Answer: Semax is a short ACTH fragment that boosts BDNF, dopamine, and serotonin signaling β sharpest impact on focus, motivation, and mood. Selank is a tuftsin analog with anxiolytic and immunomodulatory effects β best for anxiety, cognitive performance under stress, and immune support. Cerebrolysin is a porcine brain-derived peptide mixture used medically for stroke recovery, traumatic brain injury, and dementia β the most evidence-backed of the three but requires daily IV or IM injections in cycles. Semax and selank are usually intranasal and well-tolerated for daily self-use; cerebrolysin is a clinical therapy administered under medical supervision. Choice depends on goal: semax for focus, selank for anxiety, cerebrolysin for serious neurological indications.
Three Peptides, Three Philosophies
These three compounds sit at different points on the nootropic spectrum. Semax and selank evolved from Russian cognitive research in the 1980sβ1990s, designed for high-performance environments and widely used as daily intranasal sprays. Cerebrolysin took a different path β developed for stroke and brain injury, delivered by injection, and studied in multi-thousand-patient clinical trials.
Understanding the differences means understanding the history and mechanism of each, not just comparing features.
Semax: ACTH-Derived Focus Peptide
Semax is a synthetic heptapeptide derived from the ACTH(4β10) fragment. It crosses the blood-brain barrier after intranasal administration and increases BDNF, NGF, and monoaminergic neurotransmission in the prefrontal cortex and hippocampus. Its primary applications include attention deficit, depression, cognitive fatigue, and ischemic recovery.
- Typical dose: 250β1000 mcg intranasally, 1β3 times daily
- Onset: 10β30 minutes for acute focus/motivation effects
- Duration: 3β6 hours per dose
- Primary benefits: Focus, motivation, mental endurance, mood lift
- Side effects: Mild (nasal irritation, occasional headache)
Acetylated variants (N-acetyl semax, N-acetyl semax amidate) extend half-life and have slightly different receptor profiles; they're commonly preferred for stronger, longer-acting effects.
Selank: Tuftsin-Derived Anxiolytic Peptide
Selank is a synthetic analog of the naturally occurring immune-regulatory peptide tuftsin. It modulates GABA and serotonin systems, reduces anxiety without sedation, and supports immune function. Russian research has used it for generalized anxiety, burnout, and cognitive performance under pressure.
- Typical dose: 250β900 mcg intranasally, 1β3 times daily
- Onset: 15β45 minutes for anxiolytic effects
- Duration: 4β6 hours per dose
- Primary benefits: Reduced anxiety, calmer focus, better sleep quality, immune support
- Side effects: Very mild; occasional drowsiness at higher doses
N-acetyl selank amidate is the more-potent, longer-duration version now available from most research vendors.
Cerebrolysin: Medical Neuroprotective Therapy
Cerebrolysin is a proprietary peptide mixture derived from purified porcine brain protein. It contains free amino acids and low-molecular-weight peptides that together produce neurotrophic effects similar to BDNF and NGF. It is approved in many countries (not the US) for stroke recovery, traumatic brain injury, vascular dementia, and Alzheimer's disease.
- Typical dose: 5β30 mL IV or IM daily (clinically 10β30 mL)
- Cycle: 10β20 daily injections, often repeated after 3β6 months
- Onset: Cumulative effects over days to weeks
- Primary benefits: Post-stroke recovery, TBI rehabilitation, dementia symptom slowing, cognitive support in elderly
- Side effects: Injection-site reactions, occasional agitation, headache
Because cerebrolysin is a prescription therapy and requires regular injections, it is typically used in clinical or rehabilitation settings rather than as a daily self-administered nootropic.
Side-by-Side Comparison
| Factor | Semax | Selank | Cerebrolysin |
|---|---|---|---|
| Primary action | Focus, mood, BDNF | Anxiolytic, immune, GABA | Broad neurotrophic |
| Mechanism | ACTH fragment, monoamine | Tuftsin analog, GABAergic | Peptide mix, BDNF-like |
| Route | Intranasal (standard) | Intranasal (standard) | IV / IM injection |
| Typical dose | 250β1000 mcg | 250β900 mcg | 5β30 mL |
| Dosing frequency | 1β3Γ daily | 1β3Γ daily | Daily for 10β20 days |
| Onset | 10β30 min | 15β45 min | Days to weeks |
| Duration | 3β6 hr | 4β6 hr | Cumulative |
| Clinical use | Cognitive, mood | Anxiety, immune | Stroke, TBI, dementia |
| Evidence level | B β Russian studies | B β Russian studies | A β large multi-center |
| Best for | Acute focus, motivation | Anxiety, stress resilience | Serious neurological conditions |
Can You Stack Them?
Semax and selank are frequently stacked because their mechanisms are complementary: semax for focus and motivation in the morning, selank for calmer concentration or pre-anxiety events. Many users alternate doses throughout the day β semax at 7am and 12pm, selank at 3pm and evening, for example.
Cerebrolysin is rarely combined with the other two because it is typically used in discrete therapy cycles rather than daily nootropic protocols. However, patients who have finished a cerebrolysin course often transition to semax or selank for ongoing cognitive support.
All three can be combined with classical nootropics (racetams, cholinergics), amino acids (tyrosine, theanine, taurine), and adaptogens without significant interaction concerns.
Clinical Evidence Levels
Cerebrolysin has by far the strongest evidence base β multi-thousand-patient randomized trials for stroke, TBI, and Alzheimer's disease, with meta-analyses supporting modest but meaningful effect sizes on functional recovery and cognitive outcomes.
Semax and selank evidence comes predominantly from Russian academic literature. Published studies support anxiolytic and cognitive effects, though trials tend to be smaller and less rigorously blinded than Western pharmaceutical trials. In clinical settings, both peptides are used in Russia for ADHD, stroke recovery, PTSD, and general cognitive decline.
Outside these three, the broader nootropic peptide literature includes noopept, cortexin, actovegin, and others β each with its own evidence profile and use cases.
Which One Should You Choose?
Decision heuristic:
- Goal: focus, motivation, cognitive stamina β Semax (or N-acetyl semax amidate)
- Goal: anxiety reduction, calm focus, sleep β Selank (or N-acetyl selank amidate)
- Goal: both β Alternate semax in the morning, selank in the afternoon
- Goal: post-stroke / post-TBI recovery β Cerebrolysin (clinical supervision required)
- Goal: early cognitive decline / dementia support β Cerebrolysin + lifestyle + specialist evaluation
Bottom Line
Semax, selank, and cerebrolysin aren't really competitors β they occupy different niches. Semax and selank are daily-use intranasal peptides for cognitive performance and anxiety respectively, best suited to high-functioning users wanting optimization. Cerebrolysin is a prescription-grade neuroprotective therapy used for serious neurological indications. Choosing among them is less about 'which is best' and more about 'which matches your goal.' For most self-experimenting users, semax or selank is the starting point; cerebrolysin belongs in a specialist's hands.
Recommended Research Vendors
For researchers sourcing compounds discussed in this article, the following vendors maintain third-party purity testing, transparent sourcing, and established reputations in the research peptide community. WolveStack earns a small commission on referred purchases, which funds our research and writing work β this does not affect our editorial evaluation of each vendor.
π§ͺ Ascension Research
Third-party tested research peptides. Transparent COAs, reliable sourcing, and fast shipping make Ascension a top choice for researchers.
Visit Ascension β𧬠Particle Peptides
Pharma-grade purity with full HPLC/MS certificates for every batch. Particle is known for clinical-grade quality and precision research protocols.
Visit Particle βπ Limitless Life
Popular for novel and hard-to-source research compounds. Limitless offers a broad catalog of frontier peptides backed by third-party testing.
Visit Limitless βFrequently Asked Questions
Selank is clearly the better choice for anxiety. It's a direct anxiolytic that works on GABA and serotonin without sedation. Semax has mood-lifting effects but is stimulating and can actually worsen anxiety in sensitive users at higher doses.
Yes, and many users do. The combination provides focus from semax with the anxiolytic balance of selank, giving sharper cognition without the jittery edge semax alone can produce. Common schedule: semax in the morning/early afternoon, selank in the afternoon/evening.
Cerebrolysin is a purified extract of porcine brain protein, broken down into free amino acids and low-molecular-weight peptides (under 10 kDa). It contains neurotrophic-like peptides that mimic the actions of BDNF, GDNF, and NGF, supporting neuronal survival and plasticity.
For its approved indications (stroke, TBI, vascular dementia, Alzheimer's), cerebrolysin has solid evidence from multiple randomized trials and meta-analyses. Effect sizes are modest but clinically meaningful, especially for functional recovery after acute events. Outside those indications, evidence is weaker.
Peptides don't survive oral administration well, and the nasal mucosa provides relatively efficient absorption for small peptides plus a semi-direct route to the CNS via olfactory pathways. Intranasal delivery gives both fast onset and CNS penetration without injection.
Most users cycle 4β8 weeks on, 2β4 weeks off to prevent tolerance, though there's no formal recommendation. Long-term daily use (6β12+ months) is reported without obvious tolerance in many anecdotal accounts, but periodic breaks are still a reasonable practice.
Not directly. The closest analogs are Actovegin (similar origin, hemodialysate) and cortexin (another Russian porcine-brain peptide). BDNF and neurotrophic factor research is ongoing in Western pharma, but no approved direct analog of cerebrolysin is currently available in the US.
Some patients import cerebrolysin and self-administer IM injections, but this should ideally happen under medical supervision because of the dose, frequency, and monitoring requirements. Self-use without a clinician's input carries real risk of errors in dose, storage, and tracking of neurological status.
You Might Also Like
About the Author
The WolveStack research team compiles peer-reviewed scientific literature, clinical trial data, and accumulated biohacking community experience to deliver evidence-first peptide education. Our guides reflect the current state of research and common practices in the researcher community, with emphasis on critical evaluation and transparent discussion of what is and isn't known.